These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 29501817)
21. The immunomodulatory role of sulfated chitosan in BMP-2-mediated bone regeneration. Shu Y; Yu Y; Zhang S; Wang J; Xiao Y; Liu C Biomater Sci; 2018 Aug; 6(9):2496-2507. PubMed ID: 30091436 [TBL] [Abstract][Full Text] [Related]
22. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424 [TBL] [Abstract][Full Text] [Related]
23. Quinazoline analog HMJ-30 inhibits angiogenesis: involvement of endothelial cell apoptosis through ROS-JNK-mediated death receptor 5 signaling. Lu CC; Chen HP; Chiang JH; Jin YA; Kuo SC; Wu TS; Hour MJ; Yang JS; Chiu YJ Oncol Rep; 2014 Aug; 32(2):597-606. PubMed ID: 24919794 [TBL] [Abstract][Full Text] [Related]
24. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway. Liang Y; Zhang Y; Wang G; Li Y; Huang W Molecules; 2017 Jan; 22(1):. PubMed ID: 28098802 [TBL] [Abstract][Full Text] [Related]
25. Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application. Lai PX; Chen CW; Wei SC; Lin TY; Jian HJ; Lai IP; Mao JY; Hsu PH; Lin HJ; Tzou WS; Chen SY; Harroun SG; Lai JY; Huang CC Biomaterials; 2016 Dec; 109():12-22. PubMed ID: 27639528 [TBL] [Abstract][Full Text] [Related]
26. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects. Gao W; Jin K; Lan H; Han N; Cao F; Teng L Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543 [TBL] [Abstract][Full Text] [Related]
27. Synergistic effects of dual growth factor delivery from composite hydrogels incorporating 2-N,6-O-sulphated chitosan on bone regeneration. Cao L; Kong X; Lin S; Zhang S; Wang J; Liu C; Jiang X Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1-S17. PubMed ID: 30231646 [TBL] [Abstract][Full Text] [Related]
28. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs. Chuang IC; Yang CM; Song TY; Yang NC; Hu ML Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173 [TBL] [Abstract][Full Text] [Related]
29. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling. Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067 [TBL] [Abstract][Full Text] [Related]
30. Identification of resveratrol derivative 3,3',4,4',5,5'-hexamethoxy- trans-stilbene as a novel pro-angiogenic small-molecule compound. Chen Z; Zhang L; Yu J; Chen L; Zhou B Eur J Pharmacol; 2016 Nov; 791():185-194. PubMed ID: 27590357 [TBL] [Abstract][Full Text] [Related]
31. Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling. Hu WH; Duan R; Xia YT; Xiong QP; Wang HY; Chan GK; Liu SY; Dong TT; Qin QW; Tsim KW J Agric Food Chem; 2019 Jan; 67(4):1127-1137. PubMed ID: 30525561 [TBL] [Abstract][Full Text] [Related]
32. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis. Bai Y; Bai L; Zhou J; Chen H; Zhang L Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157 [TBL] [Abstract][Full Text] [Related]
33. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects. Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666 [TBL] [Abstract][Full Text] [Related]
34. Potent anti-angiogenic activity of B19--a mono-carbonyl analogue of curcumin. Sun L; Liu J; Lin SS; Shi WT; Zhu J; Liang G; Yuan ST Chin J Nat Med; 2014 Jan; 12(1):8-14. PubMed ID: 24484590 [TBL] [Abstract][Full Text] [Related]
35. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro. Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607 [TBL] [Abstract][Full Text] [Related]
36. Water extract of Cinnamomum cassia suppresses angiogenesis through inhibition of VEGF receptor 2 phosphorylation. Kim EC; Kim HJ; Kim TJ Biosci Biotechnol Biochem; 2015; 79(4):617-24. PubMed ID: 25560253 [TBL] [Abstract][Full Text] [Related]
37. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
38. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo. Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511 [TBL] [Abstract][Full Text] [Related]
39. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102 [TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis. Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]